Omeros reported $48.26M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 10.5M 37K
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Adma Biologics ADMA:US $ 35.12M 1.71M
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Cytokinetics CYTK:US $ 74.64M 17M
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Gilead Sciences GILD:US $ 3579M 392M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Insmed INSM:US $ 150.37M 1.25M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Knight Therapeutics Inc GUD:CN C$ 69.23M 3.63M
Macrogenics MGNX:US $ 68.65M 2.39M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Omeros OMER:US $ 48.26M 4.58M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Pfizer PFE:US $ 16447M 3384M
Regulus Therapeutics RGLS:US $ 8.42M 1.78M
Rockwell Medical RMTI:US $ 22.96M 0
Sangamo Biosciences SGMO:US $ 77M 427K
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
United Therapeutics UTHR:US $ 216M 10.6M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
Xoma XOMA:US $ 4.28M 20K